Endocrine testing market global industry analysis, size, share, growth trends and forecast, 2015 - 2023

Embed Size (px)

Text of Endocrine testing market global industry analysis, size, share, growth trends and forecast, 2015 -...

  • Transparency MarketResearch

    Endocrine Testing Market - Global Industry Analysis, Size, Share, GrowthTrends and Forecast, 2015 - 2023

    Global Endocrine Testing Market to Reach US$12.8 Bn by 2023, Drivenby High Incidence of Diabetes and Obesity

    Transparency Market Research State Tower,

    90, State Street, Suite 700.Albany, NY 12207United Stateswww.transparencymarketresearch.comsales@transparencymarketresearch.com

    138 Page ReportPublished Date19-Jan-2016

    Buy Now Request Sample

    Press Release

    http://www.transparencymarketresearch.com/pressrelease/endocrine-testing-market.htmhttp://www.transparencymarketresearch.com/pressrelease/endocrine-testing-market.htmhttp://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1645http://www.transparencymarketresearch.com/endocrine-testing-market.htmlhttp://www.transparencymarketresearch.com/endocrine-testing-market.htmlhttp://www.transparencymarketresearch.com/endocrine-testing-market.htmlhttp://www.transparencymarketresearch.com/

  • Endocrine Testing Market

    Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth Trends and Forecast,2015 - 2023

    According to a new market report published by Transparency Market Research Endocrine Testing Market -Global Industry Analysis, Size, Share, Growth Trends and Forecast 2015 - 2023 the global endocrinetesting market was valued at US$6.1 bn in 2014 and is estimated to reach US$12.8 bn by 2023 at a CAGRof 8.5% from 2015 to 2023.

    Browse Full Report with TOC:

    http://www.transparencymarketresearch.com/endocrine-testing-market.html

    The global endocrine testing market has been broadly segmented on the basis of selected tests, diagnostictechnologies, end-users, and geography. This report studies the current scenario as well as future marketpotential for endocrine testing globally. This report comprises an elaborate executive summary, whichincludes a market snapshot on market dynamics of various segments and sub-segments in a precisemanner. Moreover, executive summary comprises waterfall diagram, which reflects the market size ofvarious segments in descending order.

    A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the globalendocrine testing market and future opportunities has been provided in the market overview section. Thissection of the report also provides market attractiveness analysis, Porters Five Forces analysis, and marketshare analysis by key players (%) operating in the endocrine testing market.

    Based on test, the global endocrine testing market has been segmented into estradiol (E2), FollicleStimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH),Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH),prolactin, cortisol and insulin tests. The market for these tests has been extensively analyzed based onconsistency, effectiveness, and sales revenue of the various products developed by the manufacturers.The market size and forecast in terms of USD million for each type has been provided for the period from2013 to 2023. The report on the endocrine testing market also provides compound annual growth rate

    Transparency Market Research2

    REPORT DESCRIPTION

    http://www.transparencymarketresearch.com/endocrine-testing-market.html

  • Endocrine Testing Market

    (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023,considering 2014 as the base year.

    Request a Sample of Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1645

    Based on diagnostic technology, the global endocrine testing market has been segmented into five major technologies such as: tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor, and clinical chemistry technologies. The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each product (category) has been provided for the period from 2013 to 2023. The report on the tissue engineered skin substitutes market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

    The end user segmentation elucidates the global endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physicians offices. The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each product (category) has been provided for the period from 2013 to 2023. The report on the endocrine testing market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

    Geographically, the global endocrine testing market has been categorized into North America, Europe, AsiaPacific, and Rest of the World. The market size and forecast for each of these regions have been provided for the period from 2013 to 2023 along with CAGR (%) for the forecast period from 2013 to 2023. The research study also incorporates the competitive scenario of major players in these regions.

    A list of recommendations have been provided for new entrants to help establish a strong presence and forexisting market players to increase their market shares. The report concludes with the profiles of major players in the endocrine testing market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include F-Hoffmann La Roche, Ltd., Abbott Laboratories, DiaSorin, Agilent Technologies, Siemens

    Transparency Market Research3

    http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1645http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1645

  • Endocrine Testing Market

    Healthcare, Thermo Fisher Scientific, AB SCIEX LLC, Bio Rad Laboratories, Lab Corporation, bioMerieux, Sysmex Corporation, Ortho-clinical Diagnostics, Quest Diagnostics and Biomedical Diagnostics.

    The global endocrine testing market is segmented as follows:

    Global Endocrine Testing Market, by Test, 2013-2023 (USD Million)

    Estradiol (E2) Test

    Follicle Stimulating Hormone (FSH) Test

    Human Chorionic Gonadotropin (hCG) Test

    Luteinizing Hormone (LH) Test

    Dehydroepiandrosterone sulfate (DHEAS) Test

    Progesterone Test

    Testosterone Test

    Thyroid Stimulating Hormone (TSH) Test

    Prolactin Test

    Cortisol Test

    Insulin Test

    Others (Gastrin, Thymosin, Secretin, etc.)

    Global Endocrine Testing Market, by Diagnostic Technology, 2013 2023 (USD Million)

    Tandem Mass spectrometry

    Immunoassay (Enzyme immunoassays, Radioimmunoassays (RIA)) Technologies

    Monoclonal and Polyclonal Antibody Technologies

    Sensor (Electrochemical, Biosensors, etc.) Technologies

    Clinical Chemistry Technologies

    Transparency Market Research4

  • Endocrine Testing Market

    Others (Liquid Chromatography + Mass Spectrometry (LC-MS)

    Global Endocrine Testing Market, by End User, 2013 2023 (USD Million)

    Hospitals

    Commercial Laboratories

    Ambulatory Care Centers

    Home Based Tests

    Physician Offices

    Global Endocrine Testing Market, by Geography, 2013 2023 (USD Million)

    North America

    U.S.

    Canada

    Europe

    U.K.

    Germany

    Rest of Europe

    Asia Pacific

    China

    Japan

    Rest of Asia Pacific

    Rest of the World (RoW)

    Transparency Market Research5

  • Endocrine Testing Market

    Browse Full Press Release @

    http://www.transparencymarketresearch.com/pressrelease/endocrine-testing-market.htm

    Chapter 1 Preface

    1.1 Report Description

    1.2 Market Segmentation

    1.3 Research Methodology

    1.4 Assumptions

    Chapter 2 Executive Summary

    2.1 Global Endocrine Testing Market Revenue, by Diagnostic Technologies, 2014 & 2023 (Value %)

    2.2 Global Endocrine Testing Market Revenue, by End-User, 2014 & 2023 (US$ Million)

    2.3 Global Endocrine Testing Market Revenue, by Tests, 2014 (US$ Million)

    2.4 Global Endocrine Testing Market Revenue, by Geography, 2014 & 2023 (US$ Million)

    2.5 Global Endocrine Testing Market, 2014 & 2023: Market Snapshot

    Chapter 3 Industry Analysis

    3.1 Introduction

    3.2 Market Dynamics

    3.2.1 Drivers

    3.2.1.1 Increasing Incidence of diabetic and obese population worldwide

    3.2.1.2 Consistent rise in geriatric population Worldwide

    3.2.1.3 Technological advancements

    Transparency Market Research6

    TABLE OF CONTENT

    http://www.transparencymarketresearch.com/pressrelease/endocrine-testing-market.htm

  • Endocrine Testing Market

    3.2.2 Restraints

    3.2.2.1 High cost of technology

    3.2.2.2 Lack of healthcare awareness in emerging economies

    3.2.3 Opportunity

    3.2.3.1 Investment Opportunity

    3.2.4 Endocrine Testing Market: Porters Five Forces Analysis

    3.2.5 Market Attractiveness Analysis Endocrine Testing Market, by Geography, 2014